altRx vs Willow: Affordable compounded GLP-1 vs structured care
Comparing altRx vs Willow quickly: altRx emphasizes price with compounded semaglutide starting at $89/month and compounded tirzepatide at $149/month plus 100% online visits and free 2-day delivery. Willow focuses on an oral GLP-1 weight management program with licensed telehealth, progress tracking, and structured follow-up; its entry price is listed as $299. Early verdict: choose altRx if affordability and a direct-pay, online starter plan matter; choose Willow if you want structured tracking and follow-up paired with oral GLP-1 care.
Explore altRx pricing and start the 2-minute quiz
altRx vs Willow: core differences in price, format, and care
This comparison centers on the most distinctive supported differences: monthly starting price, medication format and regulatory notes, clinical and follow-up model, availability and delivery, and program positioning. All statements below preserve the exact qualifiers supplied in the source evidence.
1) Price and pricing details
altRx offers a limited offer with compounded semaglutide starting at $89/month and compounded tirzepatide starting at $149/month. The altRx FAQ notes multi-month plan pricing tiers (example reductions on 3-, 6-, and 12-month plans) and buy now, pay later options through Affirm, Klarna, and Afterpay. Willow is listed with an entry price of $299. The source describes Willow as having higher monthly entry pricing for some plans but does not supply additional fee details.
See altRx plan details and payment options
2) Medication format and regulatory notes
altRx provides compounded GLP-1 medications: the evidence repeatedly states compounded semaglutide and compounded tirzepatide, and includes the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Willow offers an oral GLP-1 program; the captured evidence also notes that when compounded medications are offered, they are not FDA-approved and not reviewed by FDA for safety, effectiveness or quality. The sources therefore preserve that compounded status and regulatory caution for each provider when relevant.
3) Care model and follow-up
altRx is built around 100% online medical visits with telehealth evaluation and ongoing clinician-guided support; a licensed provider reviews evaluations and may conduct live video or asynchronous reviews per state law. altRx emphasizes no membership or hidden fees, cancel anytime, and includes a care team available throughout membership. Willow is described as telehealth-first with licensed clinicians plus progress tracking tools and follow-up consultations; its positioning emphasizes structured behavioral support and follow-up to convert medication efficacy into sustainable outcomes. Treatment at Willow is available only when a licensed clinician determines it is medically appropriate.
4) Availability, shipping, and delivery timing
altRx states free and discreet 2-day delivery and typical processing and delivery time of approximately 4–5 business days once prescribed; it also states the membership is available to residents of all 50 U.S. states with provider availability varying by state. For Willow, the captured landing-page evidence was limited and did not verify shipping, fees, membership, cancellation, or specific state availability details.
Comparison table: altRx vs Willow
| Criteria | altRx | Willow |
|---|---|---|
| Starting price | Compounded semaglutide from $89/mo; tirzepatide from $149/mo | $299 starting price (entry price listed) |
| Medication format | Compounded GLP-1s (semaglutide, tirzepatide) | Oral GLP-1 program; compounded status noted when offered |
| Care model | 100% online medical visits, ongoing care team support | Telehealth-first with licensed team, progress tracking, and follow-up |
| Delivery | Free, discreet 2-day delivery; typical 4-5 business days processing | Not verified on captured page |
| Regulatory note | Compounded medications are not FDA-approved and not reviewed by FDA | Medication-specific approval status must be confirmed; branded and compounded products not interchangeable |
5) Program positioning and best for
altRx is described as the most affordable GLP-1 program on the market and is best for patients who were held back by price. Willow is positioned as a structured weight management journey that emphasizes progress tracking and behavioral scaffolding and is best for users who want structured digital follow-up.
Learn about Willow’s tracking and follow-up
Regulatory and availability cautions appear in both sources: altRx explicitly states compounded medications are not FDA-approved. Willow’s captured evidence notes that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable. Where the source did not provide information, such as detailed shipping or cancellation terms for Willow, that information is not supplied here.
Start altRx now and review eligibility
Conclusion: choose based on cost or structured support
For a quick recap of altRx vs Willow: altRx emphasizes low starting prices for compounded semaglutide ($89/mo) and tirzepatide ($149/mo), 100% online visits, free 2-day delivery, and a direct-pay model. Willow emphasizes an oral GLP-1 pathway with licensed telehealth, progress tracking, and structured follow-up with an entry price of $299 and higher monthly entry pricing for some plans.
Choose altRx if you need the most affordable, online-first GLP-1 program with compounded semaglutide or tirzepatide and free 2-day delivery, and you accept that compounded medications are not FDA-approved. Choose Willow if you prefer an oral GLP-1 program built as a structured weight management journey with progress tracking and follow-up from a licensed telehealth team.